Milner Therapeutics Symposium showcases innovation in translational science
This week, the Milner Therapeutics Institute hosted its annual Symposium – a hybrid event welcoming approximately 500 in-person delegates and 250+ online attendees. Hosted at West Road Concert Hall in Cambridge, UK, the Symposium brings together leading minds from...
Milner Institute prepares for upcoming Therapeutics Symposium and Pitch Day
We are excited for several Milner events taking place across Cambridge next week, including our annual Therapeutics Symposium and Pitch Day. The Milner Therapeutics Symposium will take place on 30 June, and is an opportunity for scientists from academia and industry...
Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics
Shift Bioscience, a company based in the Milner Institute Bio-incubator, has published new research identifying a novel, single-gene target for cellular rejuvenation. Capable of reversing cellular aging across multiple cell types, without inducing dangerous...
Milner Institute begins collaboration with Yonsei University for joint research in quantum computing
We were delighted to host a signing ceremony with Yonsei University last week, for a new Memorandum of Understanding (MOU) between our institute at the University of Cambridge, Cambridge Stem Cell Institute, and the Cambridge Centre for AI in Medicine. This agreement...
Milner Institute delivers Cambridge-Google AlphaFold Workshop
We were delighted to welcome over 120 delegates in Cambridge last week, for a Cambridge-Google Workshop: Learning from Experts in Computational Biology and AI. The event was jointly organised by the Milner Therapeutics Institute, Cambridge AI Club for Biomedicine, and...
Milner Institute highlights in-house research capabilities at Cambridge Festival
The Milner Institute was delighted to take part in two Cambridge Festival events again this year. Held each spring, the Festival features a mix of online, on-demand, and in-person events, showcasing the groundbreaking research taking place across Cambridge. On 22...
Milner Institute hosts official opening of new Functional Genomics Screening Laboratory
Last week, we were delighted to launch the new Functional Genomics Screening Laboratory (FGSL) here at the Milner Therapeutics Institute in Cambridge, UK. The new lab will support world-class research and innovation in the rapidly advancing field of functional...
Milner Therapeutics Consortium renewed for five years
We are delighted that the Milner Therapeutics Consortium has been renewed until 2029, which will continue to provide opportunities for our academic and business communities to engage with pharma at an early stage. The Milner Therapeutics Consortium has been active...